Fitzsimons Innovation Community is an integrated urban campus where health and life sciences companies of all sizes work on their next big things. Our customized workspace, collaborative campus, and proximity to one of the top health systems and medical schools in the country make our community the perfect place to put down roots and get to work.
MOVE-IN READY LAB SPACE
GROWTH OPPORTUNITIES
It’s not just additional space—it’s fifty sprawling acres of additional space. And it’s primed for ultra-custom, made-to-order facility development.
Fitzsimons Innovation Community and University of Colorado Anschutz Medical Campus working together.
Relationships that help you thrive.
FEATURED:
One of the most exciting times of year for us here at Fitzsimons Innovation Community is when we launch our Annual Innovation Report, and this year is no different. For the fourth year in a row, we are proud to share this report featuring updates, insight, and data about all the things that make our Community special.
Fitzsimons Innovation Community is where innovators come to turn ideas into business.
A regular feature of a Fitzsimons Innovation Community visionary.
Our year in innovation.
Find out what’s happening on campus and across the industry.
An urban mountain lifestyle for work and play.
Everything you need.
Right here.
The Global Business Development division of the Colorado Office of Economic Development and International Trade (OEDIT) announced that 17 Colorado companies and eight researchers have been awarded Proof of Concept and Early-Stage Capital and Retention grants through OEDIT’s Advanced Industries Accelerator Program. Congratulations to the Fitzsimons Innovation Community Early-Stage Capital and Retention Grant Recipients: Onconaut Therapeutics, Inc., Vega Surgical, Inc., and Vona Oncology LLC.
UCHealth said it's the first in Colorado to offer a kind of mammogram that could be a game changer when it comes to detecting breast cancer. Dr. Elizabeth Vorhis, a breast radiologist said she uses an IV contrast during a mammogram. It's the same kind of process if you go to the emergency room and get a stomach or chest CT scan.
Colorado BioScience Association (CBSA) announced the winners of its 22nd Annual Awards Celebration, recognizing the people and organizations advancing Colorado’s position as a leading hub for health innovation. The awards spotlight leaders whose work accelerates breakthrough discoveries and delivers impact for patients in Colorado and around the world. Dr. Katherine Goodman, Associate Professor at the University of Colorado Denver | Anschutz, received the Educator of the Year Award for her outstanding contributions to shaping Colorado’s future life sciences workforce. EnteroTrack and RheumaGen were honored as Rising Star of the Year finalists.
Earlier this year, Kate Goes became the first patient in North America to use FDA-approved adaptive deep brain stimulation (DBS) technology for Parkinson’s. UCHealth Ph.D. clinical neuropsychologist John Thompson helped make the pathbreaking innovation possible.
Earlier this year, Kate Goes became the first patient in North America to use FDA-approved adaptive deep brain stimulation (DBS) technology for Parkinson’s. UCHealth Ph.D. clinical neuropsychologist John Thompson helped make the pathbreaking innovation possible.
Earlier this year, Kate Goes became the first patient in North America to use FDA-approved adaptive deep brain stimulation (DBS) technology for Parkinson’s. UCHealth Ph.D. clinical neuropsychologist John Thompson helped make the pathbreaking innovation possible.
The University of Colorado system generated $12.2 billion in economic impact across Colorado last year, highlighting CU’s growing role in the state’s economy through education, research, innovation and health care, according to a new economic study. This is growth of more than half a billion dollars over 2024.
Colorado Real Estate Journal's latest Health Care and Life Sciences Quarterly features an article from Dr. Terry Fry, Executive Director of the Gates Institute at University of Colorado Anschutz, about how the proximity between academia, biomanufacturing, and industry collaboration at Fitzsimons accelerates the development of life-changing cell and gene therapies.
Precision health and medicine giant Verily will be partnering with CU Anschutz and UCHealth to create an AI enabled ecosystem entailing research ready biomedical pipelines and datasets. In addition, the partnership is aiming to build curated AI models across a variety of specific therapeutic and drug areas, such as oncology, musculoskeletal and transplant medicine, to name a few. All of this work will be done using CU Anschutz’s vast research datasets via Verily Workbench, one of the company’s flagship products.
RheumaGen, Inc. and SiVEC Biotechnologies, Inc. today announced a licensing and joint development agreement for a breakthrough class of gene-editing therapies designed to cure autoimmune diseases. The partnership will utilize SiVEC's BactPac™ drug delivery platform to streamline manufacturing and increase scalability of RheumaGen's new class of human leukocyte antigen (HLA) gene-editing therapies for common autoimmune diseases; importantly, the partnership also establishes an in vivo program that will be co-developed by the companies.
EnteroTrack LLC announced that the Centers for Medicare & Medicaid Services (CMS) is paying for the company’s Esophageal String Test® (EST), marking a major milestone in access for patients living with eosinophilic esophagitis (EoE), a chronic inflammatory condition of the esophagus. The decision means that Medicare beneficiaries can now receive coverage for the EST, which provides a non-endoscopic, minimally invasive method to monitor esophageal inflammation. The test enables clinicians to track disease activity without the need for repeated sedated endoscopies, which are costly, burdensome, and carry procedural risks.
Change Please was named one of Instawork’s Community Partner of the Year winners for 2025. The Community Partner Awards recognized businesses prioritizing hiring from underserved local communities. With a Denver area location at Fitzsimons Innovation Community, the Change Please mission is to tackle homelessness through employment, training, and holistic support is transforming lives.
Fitzsimons Innovation Community
